DD119425A5 - - Google Patents

Info

Publication number
DD119425A5
DD119425A5 DD185117A DD18511775A DD119425A5 DD 119425 A5 DD119425 A5 DD 119425A5 DD 185117 A DD185117 A DD 185117A DD 18511775 A DD18511775 A DD 18511775A DD 119425 A5 DD119425 A5 DD 119425A5
Authority
DD
German Democratic Republic
Application number
DD185117A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD119425A5 publication Critical patent/DD119425A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD185117A 1974-04-01 1975-04-01 DD119425A5 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45679774A 1974-04-01 1974-04-01
US54722775A 1975-02-05 1975-02-05
US55496675A 1975-03-03 1975-03-03

Publications (1)

Publication Number Publication Date
DD119425A5 true DD119425A5 (fr) 1976-04-20

Family

ID=27412681

Family Applications (1)

Application Number Title Priority Date Filing Date
DD185117A DD119425A5 (fr) 1974-04-01 1975-04-01

Country Status (14)

Country Link
JP (1) JPS5427360B2 (fr)
CA (1) CA1033731A (fr)
DD (1) DD119425A5 (fr)
DE (1) DE2513930A1 (fr)
DK (1) DK138743B (fr)
ES (1) ES436155A1 (fr)
FI (1) FI750891A (fr)
FR (1) FR2265389B1 (fr)
GB (1) GB1451423A (fr)
IE (1) IE40893B1 (fr)
IL (1) IL46864A0 (fr)
LU (1) LU72184A1 (fr)
NL (1) NL7503692A (fr)
PH (1) PH10464A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075343A (en) * 1976-09-13 1978-02-21 Pfizer Inc. Anti-allergenic 5-alkoxyimidazo[1,2-A]quinoline-2-carboxylic acids and derivatives thereof
US4127720A (en) * 1977-09-21 1978-11-28 Bristol-Myers Company Pyrimido[2,1-a]isoquinoline derivatives having antiallergy activity
US4209620A (en) * 1978-06-19 1980-06-24 Bristol-Myers Company Substituted 3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives having antiallergy activity
US4472401A (en) * 1981-11-27 1984-09-18 Roussel Uclaf Pyrimido-quinoxalines having antiallergic properties
US4510143A (en) * 1982-02-17 1985-04-09 Roussel Uclaf Antiallergic pyrimido[1,2-a]quinoxalin-2-carboxylic acid derivatives
WO1997037999A1 (fr) * 1996-04-04 1997-10-16 University Of Nebraska Board Of Regents Composes synthetiques formant une triple helice
US6989392B2 (en) 2002-06-18 2006-01-24 Abbott Laboratories 2-Aminoquinolines as melanin concentrating hormone receptor antagonists

Also Published As

Publication number Publication date
IE40893L (en) 1975-10-01
AU7937775A (en) 1976-09-23
GB1451423A (en) 1976-10-06
IL46864A0 (en) 1975-05-22
JPS50140499A (fr) 1975-11-11
ES436155A1 (es) 1977-02-01
FI750891A (fr) 1975-10-02
DK130475A (fr) 1975-10-02
DK138743B (da) 1978-10-23
PH10464A (en) 1977-04-25
FR2265389A1 (fr) 1975-10-24
NL7503692A (nl) 1975-10-03
JPS5427360B2 (fr) 1979-09-10
IE40893B1 (en) 1979-09-12
DE2513930A1 (de) 1975-10-02
LU72184A1 (fr) 1976-03-02
DK138743C (fr) 1979-04-02
CA1033731A (fr) 1978-06-27
FR2265389B1 (fr) 1978-07-28

Similar Documents

Publication Publication Date Title
FR2259647A1 (fr)
FR2269937A1 (fr)
FR2272949A1 (fr)
DK134689C (fr)
FR2276671B1 (fr)
FR2294325B1 (fr)
FR2295227B1 (fr)
FR2262714A1 (fr)
FR2263712A1 (fr)
FI750433A (fr)
FR2280349B2 (fr)
FR2270142B1 (fr)
JPS50103746A (fr)
FR2272508A1 (fr)
JPS50101503U (fr)
BG21634A1 (fr)
CH17274A4 (fr)
CH613715A5 (fr)
CH604033A5 (fr)
CH585399A5 (fr)
CH574312A5 (fr)
CH569666A5 (fr)
CH569220A5 (fr)
CH568539A5 (fr)
BG22040A1 (fr)